After our last session in STING, where we defined better the problems we are trying to solve, our favorite customer and what would be our value proposition, we are aiming to define the channels in which we would make our product available, and how.

Also, following the Lean Startup methodology, we are aiming to define our first Minimum Viable Product, or MVP.

The MVP is a product with the minimum features in order to gather validated learnings about our product and its continued development. Not only gathering insights from an MVP is often less expensive than developing a product with more features, but also has the great advantage of versatility, as it permits to rapidly follow the build → measure → learn cycle.

Build – Measure – Learn

Of course, validating learnings through an MVP avoids the increased costs and risks if the product fails, for example, due to incorrect assumptions, if we were building it for months without testing our hypothesis. A significative difference between an MVP and a prototype is that we are also aiming to test the business viability of our product (although we would probably won’t make a profit out of it… yet!).

The office, full of life again!

It is also very enjoyable to have the company of Team O with us at Fleminsberg, as we develop our first MVP conception. It is always good to test how crazy our ideas can be, from people that have walked the Clinical Innovation Fellowships with us!

(You can always reach us by sending an e-mail to: teaminfection@clinicalinnovation.se)

José (Team Infection)

This week has been full of hard work, as we are having more time, day by day, week by week, to solely focus in our business project. Every little step we take towards it unfolds a vast field of questions, known unknowns and unknown unknowns. We have hypothesis everywhere, that only can be proved or refuted through a conscious effort in testing, failing and learning from it.

But we are willing to get our hands dirty, and let the market or the stakeholders tell us how wrong or right we are, pursuing this road less traveled by.

As we advanced last week, our students met with the Reference Group, as they presented the needs they are working with, as well as their plans, objectives and resources. They did an excellent job and we are very proud of them, just don’t tell them, there is a lot of work ahead yet.

We also had the opportunity to openly discuss with the Group the Clinical Report we have been compiling, in order to get feedback. As we were wishing, we clashed in some of our proposals and laudations in some other… but looking at the overall feeling, it seems that the were pleased with our work. Let us hope it really makes a difference and eases the path for future collaborations with Danderyds Sjukhus.

Speaking about getting our hands dirty, that can sometimes mean meetings and fika, at least here in Stockholm, where we were kindly invited to learn about HIP SDK, an innovation framework that enables access to data in Swedish healthcare.

At the HIP SDK meeting

We got a very interesting insight about how Sweden in pioneer in access to medical data and how could we work with that in our future projects.

(You can always reach us by sending an e-mail to: teaminfection@clinicalinnovation.se)

José (Team Infection)

We have just finished the draft for the clinical report that shall be delivered to the Infectious Diseases clinic and distributed to other wards at Danderyds Sjukhus.

It has been sent to our Reference Group of experts at the clinic, in order to get their feedback and iterate. This way, we will deliver a more valuable report, while they will get on-spot solutions and suggestions for improvement.

This week we met as well our Business Mentors, which gave their feedback about how are we addressing our commercial project and what could be our next course of action in the upcoming weeks. We look forward to meet them again and share our progress.

Last but not least, we had two workshops about IP, delivered by Simon Curtis, from Potter Clarkson, where we learned about what to take into account on patent research as well as intellectual property protection. We also enjoyed a workshop about reimbursement, kindly delivered by BcG.

We are looking forward for next week’s Reference Group meeting, in order to get valuable feedback for our report and present our Master’s Thesis students projects to the clinic.

(You can always reach us by sending an e-mail to: teaminfection@clinicalinnovation.se)

José (Team Infection)

We started this week working in the Clinical Report that we will deliver to the Infectious Diseases Clinic. As is it our intention to validate our proposals as far as possible, we are back at Danderyds Sjukhus, testing some solutions and making interviews. Our list of solutions is as big Stanley Kubrick’s aperture, so we really have to select the right ones.

We were also invited to the new infectious diseases’ ward, which is located beneath ward 4. New facilities, new personnel, single patient rooms and a different frameworks are some of the characteristics that prevail in this new stage. We thank them for the invitation, as our curiosity sense bellows for knowing how the staff and procedures will adapt to the expansion.

Inauguration of the new ward

We have also been working on our need and meeting potential customers in order to get some insight about the problem we are trying to solve, who is the crying costumer and what could be an early stage adopter, flashed by our solution.

This week we also had a photo session with Team O, as we still had the need to have some pictures of our clinical experiences, for promo and storytelling. I guess the best ones were the ones that were the most “al naturel”.

Bad-ass photo for bad-ass teams

We are now finishing the draft of Clinical Report that we will send to the clinic for evaluation, hoping that they find their needs portrayed and taken into account, with the aim of (humbly) betterment, as much as possible, our beloved host clinic.

(You can always reach us by sending an e-mail to: teaminfection@clinicalinnovation.se)

José (Team Infection)

Starting the week with STING, at the STING Test Drive in H2, we were introduced to the Lean Canvas (inspired by the Business Canvas and by Lean Startup), an entrepreneur-focused business plan, as it mainly focuses in problems, solutions, key metrics and competitive advantages. Other 10 teams will be accompanying us through the Test Drive, where we will be provided with valuable tools for our start-up’s development.

STING Test Drive

On Wednesday, we were invited by a consultancy agency focused on healthcare (and workplace of one of the Fellows), Sirona. We thank them for the tools they gave us for stakeholder analysis, and how ignoring a key player could kill any changes we wish to bring to healthcare.

Mapping the stakeholders, strategically close to the candy

On Thursday we had the privilege to play CIF’s renowned yearly tradition, since the first edition: wheelchair basketball. That and the dinner we had after with Clinical Innovation Fellows from all editions was a great opportunity to mingle and share experiences.

Dinner time!

Last, but not least, we had a presentation on Danderyd Sjukhus to our Master Thesis students, where we introduced the clinic to them. From facts to figures, must do’s and mustn’ts, clinical etiquette and frameworks, we tried to transmit our previous experience to them, learned from our shadowing experience.

(You can always reach us by sending an e-mail to: teaminfection@clinicalinnovation.se)

José (Team Infection)